Skip to main content
OpenTrials
Completed

NCT Number: NCT03186508

Enhancing Sleep Duration: Effects on Children's Eating and Activity Behaviors-Renewal

Enhancing children's sleep may be a novel approach for prevention of obesity and cardiovascular (CV) disturbance. Observational studies with children demonstrate that short sleep increases risk of obesity and other CV risk factors. Randomized controlled trials with children 8-11 years old demonstrate that enhancing sleep duration leads to positive changes in eating and activity behaviors and weight status, particularly for children who enhance their sleep the most. Enhancing sleep may be particularly important for racial minority children and those from lower socioeconomic backgrounds given their increased risk for short sleep, obesity and CV risk factors. In this study two active obesity preventive interventions will be evaluated: a) enhancing sleep alone (Optimize Sleep [OS]), and b) enhancing sleep along with eating and activity behaviors that have demonstrated efficacy for obesity prevention and are implicated in self-regulatory pathways related to sleep (i.e., energy dense snack foods and beverages, TV viewing, and physical activity) (OS-Plus). Two hundred four children 6-11 years old who are primarily African American/black, primarily from low socioeconomic backgrounds, and who sleep < 9.5 hours/night into a 12-month study will be enrolled. Children will be randomly assigned to either OS or OS-Plus. Over the 6-month treatment phase, all children will attend an 8-session treatment; monthly phone contacts will occur during maintenance (6-12 months). Primary aim is to determine the efficacy of OS-Plus relative to OS on change in body mass index z-score (BMIz) at end of treatment. Secondary aims will assess efficacy of OS-Plus relative to OS on additional cardiometabolic risk factors, eating and activity behaviors. Exploratory aims will assess maintenance of effects at 12 months.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 year–11 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Temple University

Philadelphia, Pennsylvania, 19122-6091, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Caregiver-reported child age of 6-11 years
  • < 9.5 Hours time-in-bed for sleep most days/week
  • BMI for age and gender > 25th percentile (but no greater than 100% overweight)
  • Understanding of and ability to complete protocol
  • Self-reported caregiver age of 18 years and primary caregiver at bedtimes/wake times
  • Likes food used in the eating regulation paradigms
  • Willingness to be randomized to either treatment condition.

Exclusion criteria

  • Diagnosable sleep disorder
  • Medication use or diagnosis of medical or psychiatric condition that may impact sleep/weight status
  • Current or planned treatment for weight control
  • Allergies or dietary restrictions that would prevent consumption of foods used in the study

Treatment and study plan

Optimize Sleep (OS)

Behavioral

All children will receive 8 sessions during active treatment: two in-person weekly, three in-person biweekly, and 3 monthly sessions conducted by phone. All families will be asked to complete 3 "sleep challenges" (at weeks 8, 16, and 20). During maintenance, families will continue with monthly phone contact.

Optimize Sleep-Plus (OS-Plus)

Behavioral

All children will receive 8 sessions during active treatment: two in-person weekly, three in-person biweekly, and 3 monthly sessions conducted by phone. All families will be asked to complete 3 "sleep challenges" (at weeks 8, 16, and 20). During maintenance, families will continue with monthly phone contact.

Primary outcomes

  1. Change in BMIz

    Time frame: Change from baseline BMIz at 6 months

    change in body mass index z-score (accounting for child age and sex)

Secondary outcomes

  1. Change in Body Composition

    Time frame: Change from baseline percent body fat at 6 months

    change in body composition (% body fat) will be estimated by air displacement plethysmography (BOD POD®; Life Measurement Instruments, Concord, CA)

  2. Change in Waist Circumference

    Time frame: Change from baseline waist circumference at 6 months

    Change in measured waist circumference

  3. Change in Insulin Resistance

    Time frame: Change from baseline HOMA-IR at 6 months

    Change in the homeostatic model assessment of insulin resistance (HOMA-IR)

  4. Change in Blood Glucose Levels

    Time frame: Change from baseline blood glucose levels at 6 months

    2-hour blood glucose levels measured within the context of an oral glucose tolerance test

  5. Change in Non-HDL cholesterol (non-HDL-C)

    Time frame: Change from baseline in Non-HDL-C at 6 months

    Total cholesterol (TC) minus HDL-C, includes LDL-C, VLDL-C, and atherogenic apo-B containing lipoproteins

  6. Change in Insulin Sensitivity Index (ISI)

    Time frame: Change from baseline ISI at 6 months

    Insulin Sensitivity Index measured within the context of an oral glucose tolerance test

  7. Change in Sleep Period

    Time frame: Change from baseline in the sleep period at 6 months

    Wrist-worn actigraphy

  8. Change in Caloric Intake

    Time frame: Change from baseline in caloric intake at 6 months

    24-hr dietary recalls on two days used to estimate caloric intake

  9. Change in Food Reinforcement

    Time frame: Change from baseline in food reinforcement at 6 months

    Measured using a validated computer activity (Behavioral Choice Task), which assesses motivation for a food reward

  10. Change in Eating in the Absence of Hunger (EAH)

    Time frame: Change from baseline in EAH at 6 months

    Food consumed within the context of the eating in the absence of hunger paradigm

  11. Change in Percent Time spent in Moderate to Vigorous Physical Activity (MVPA)

    Time frame: Change from baseline in MVPA at 6 months

    Waist-worn accelerometer

Sponsors and collaborators

Lead sponsor

Temple University

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Important dates

Study start
2018
Primary completion
2023
Study completion
2023
First posted
Jun 14, 2017
Registry last updated
Oct 28, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.